Fujifilm launches new device aimed at simplifying endoscopic lesion extraction
FUJIFILM Healthcare Americas Corporation, a provider of endoscopic and endosurgical innovations, is launching TRACMOTION, the company's new device for endoscopic submucosal dissection (ESD) at the New York Society of Gastrointestinal Endoscopy (NYSGE) Conference both #400, held December 16-17.
ESD is a viable alternative to piecemeal resection or invasive surgery, and is utilized for en bloc resection of large, potentially cancerous polyps or tumors in the gastrointestinal tract. Inserted through the instrument channel of an endoscope, TRACMOTION’s 360° rotatable jaws enable easy grasping and re-grasping of large lesions, which enhances a clinicians visualization, simplifies the lesion extraction process and offers the potential to reduce ESD procedure times.
With TRACMOTION, an endoscopist uses simple single-hand movements to control the distal end of the product, independent of the endoscope’s movement. TRACMOTION can hold tissue during ESD without complicated locking mechanisms, demonstrating additional efficiencies when used during this advanced procedure.
TRACMOTION was designed to be used with Fujifilm’s newly-launched EI-740D/S, a dual-channel endoscope cleared by the U.S. Food and Drug Administration (FDA) for use in both upper and lower gastrointestinal applications. The endoscope features two instrument channels so clinicians can perform procedures that require a range of instruments and devices, including Fujifilm’s ClutchCutter and FlushKnife.
